Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37
Published September 3, 2025 · Recall initiated: August 11, 2025
Summary
FDA records drug Class II recall D-0599-2025, published September 3, 2025 and initiated August 11, 2025. Recalling firm: Lannett Company Inc.; Status: Terminated; Reported quantity: 8544 bottles; Lot: Lot #: 25280726A, Exp. Date 03/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if LISDEXAMFETAMINE DIMESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer
- Lannett Company Inc.
- Distributor
- Nationwide within the USA
- UPC
- 0305274664379
- Lot
- Lot #: 25280726A, Exp. Date 03/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDALisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHMNovember 5, 2025
- FDASucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging,September 3, 2025
- FDAMedline Alcohol Prep Pads, 70% Isopropyl Alcohol, 100 Sterile 2-Ply Pads, Single Use Only, Large,September 3, 2025
Questions about this recall
Was Lisdexamfetamine Dimesylate Capsules, 40 mg, 100-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC 0527-4664-37 recalled?
Yes. FDA published recall D-0599-2025 on September 3, 2025. Reported hazard: Labeling: Label Mix-up. A bottle labeled as Lisdexamphetamine Dimesylate Capsules 40mg, contained Lisdexamphetamine Dimesylate Capsules 30mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LISDEXAMFETAMINE DIMESYLATE. UPC: 0305274664379.